Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Witteveen J et al. – The cure rate of sporadic primary hyperparathyroidism after initial surgery is 93%. When cure is achieved, this is sustained in 100% of patients for up to 24 years post–operatively. The data suggest that closer early follow–up is advocated in all patients undergoing PTx to definitively establish cure and to provide a safety net for those with residual gland pathology. The data do not support the need for long term follow–up when cure is established 6 months after PTx.

Related Articles

Postexercise Cardiac Performance Among Patients With Mild Primary Hyperparathyroidism
The Endocrinologist, 11/16/09    Relevance Score: 68%

Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism
Diabetic Medicine, 10/02/09    Relevance Score: 67%

Nonoperative management of primary hyperparathyroidism: the exception rather than the rule
Expert Review of Endocrinology & Metabolism, 11/17/09    Relevance Score: 66%

Cinacalcet Treatment of Primary Hyperparathyroidism: Biochemical and Bone Densitometric Outcomes in a Five-Year Study
Journal of Clinical Endocrinology and Metabolism, 10/21/09    Relevance Score: 66%

Single Photon Emission Computed Tomography (SPECT) Should be Routinely Performed for the Detection of Parathyroid Abnormalities Utilizing Technetium-99m Sestamibi Parathyroid Scintigraphy
Clinical Nuclear Medicine, 10/07/09    Relevance Score: 66%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address